Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver

被引:16
|
作者
Schrader E. [1 ]
Hirsch-Ernst K.I. [1 ]
Richter E. [2 ]
Foth H. [3 ]
机构
[1] Institute of Toxicology, University of Göttingen, D-37075 Göttingen
[2] Walther-Straub Inst. Pharmacol. T., Ludwig Maximilians Univ. Munchen, D-80336 München
[3] Inst. of Environmental Toxicology, Martin Luther Univ. Halle-Wittenberg, D-06097 Halle/Saale
关键词
Elimination kinetics; Liver; Lung; Metabolism; N-oxide; NNK; Perfusion; Rat;
D O I
10.1007/PL00005176
中图分类号
学科分类号
摘要
The tobacco specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a strong lung carcinogen in all species tested. To elicit its tumorigenic effects NNK requires metabolic activation which is supposed to take place via a-hydroxylation, whereas N-oxidation is suggested to be a detoxification pathway. The differences in the organ specific metabolism of NNK may be crucial for the organotropy in NNK-induced carcinogenesis. Therefore, metabolism of NNK was investigated in the target organ lung and in liver of Fischer 344 (F344) rats using the model of isolated perfused organs. High activity to metabolize 35 nM [5-3H]NNK was observed in both perfused organs. NNK was eliminated by liver substantially faster (clearance 6.9 ± 1.6 ml/min, half-life 14.6 ± 1.2 min) than by lung (clearance 2.1 ± 0.5 ml/min, half-life 47.9 ± 7.4 min). When the clearance is calculated for a gram of organ or for metabolically active cell forms, the risk with respect to carcinogenic mechanisms was higher in lung than in liver. The metabolism of NNK in liver yielded the two products of NNK α-hydroxylation, the 4-oxo-4-(3-pyridyl)-butyric acid (keto acid) and 4-hydroxy-4-(3-pyridyl)-butyric acid (hydroxy acid). In lung, the major metabolite of NNK was 4-(methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanone (NNK-N-oxide). Substantial amounts of metabolites formed from methyl hydroxylation of NNK, which is one of the two possible pathways of α-hydroxylation, were detected in lung but not in liver perfusion. Formation of these metabolites (4-oxo-4-(3-pyridyl)-butanol (keto alcohol), and 4-hydroxy-4-(3-pyridyl)-butanol (diol) can give rise to pyridyloxobutylating of DNA. When isolated rat livers were perfused with 150 μM NNK, equal to a dosage which is sufficient to induce liver tumors in rat, glucuronidation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) was increased when compared to the concentration of 35 nM NNK. Nevertheless, the main part of NNK was also transformed via α-hydroxylation for this high concentration of NNK.
引用
收藏
页码:336 / 343
页数:7
相关论文
共 50 条
  • [1] Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rhesus monkeys
    Meger, MHE
    Richter, E
    Zwickenpflug, W
    Hargaden, MB
    ARahim, YI
    Vesell, ES
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 619 - 619
  • [2] Detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by glucuronidation
    Murphy, SE
    Spina, DA
    Pullo, DA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 62 - TOXI
  • [3] Metabolism and disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rhesus monkeys
    Meger, M
    Richter, E
    Zwickenpflug, W
    Oehlmann, C
    Hargaden, MB
    A-Rahim, YI
    Vesell, ES
    [J]. DRUG METABOLISM AND DISPOSITION, 1999, 27 (04) : 471 - 478
  • [4] Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human placental microsomes
    Collazo, NR
    Sultatos, LG
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (11) : 1933 - 1941
  • [5] Effects of quercetin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolizing enzymes in rat lung
    Liu, Ying-Hui
    Peng, Ren-Xiu
    Wu, Jun-Yu
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 383 - 383
  • [6] INHIBITION OF THE METABOLISM AND GENOTOXICITY OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN RAT HEPATOCYTES BY (+)-CATECHIN
    LIU, L
    CASTONGUAY, A
    [J]. CARCINOGENESIS, 1991, 12 (07) : 1203 - 1208
  • [7] Biomonitoring of the exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in nonsmokers
    Meger, M
    Meger-Kossien, I
    Scherer, G
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R126 - R126
  • [8] The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo
    Sellers, EM
    Ramamoorthy, Y
    Zeman, MV
    Djordjevic, MV
    Tyndale, RF
    [J]. NICOTINE & TOBACCO RESEARCH, 2003, 5 (06) : 891 - 899
  • [9] Effect of nicotine or cotinine on metabolism of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver
    Schulze, J
    Schrader, E
    Foth, H
    Kahl, GF
    Richter, E
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (03) : 344 - 350
  • [10] Effect of nicotine or cotinine on metabolism of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver
    Johannes Schulze
    Eberhard Schrader
    Heidi Foth
    Georg F. Kahl
    E. Richter
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 1998, 357 : 344 - 350